Development of a 3D tumor model based on decellularized matrix using high-throughput approaches
Siahmansouri H., Fenoglio D., Filaci G., Mastrogiacomo M.
Narrative Review, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Bioeng Biotechnol (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41641335
- PMCID
- PMC12864436
- DOI
- 10.3389/fbioe.2025.1690844
Abstract (original English)
Precision medicine aims to develop 3D tumor models to validate new therapies and investigate disease mechanisms by isolating the extracellular matrix as a foundation for recreating tumors in vitro . The use of decellularized tumor matrices offers a promising and versatile platform for in vitro cancer research and therapeutic testing. The tumor microenvironment (TME) is the surrounding milieu of cancerous tissues and contains an intricate network of extracellular matrix (ECM) components and signaling proteins that regulate tumorigenesis, invasion, and metastasis. However, the decellularization techniques process can be disruptive and often damage essential macromolecules and proteins, potentially compromising the restoration of a biologically relevant microenvironment during recellularization. This review explores the most relevant macromolecules and proteins within the TME, emphasizing their roles in tumors and metastasis. Here, the potential of reinstating these components into decellularized tumor scaffolds to enhance their biological relevance and functionality is highlighted. Key macromolecules, including collagen, fibronectin, hyaluronic acid (HA), and laminin, are discussed alongside the contributions of proteins such as integrins, matrix metalloproteinases (MMPs), and growth factors to ECM remodeling, cell adhesion, migration, and proliferation. The strategic reintroduct
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.